Wanders A - Search Results

1

Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation.

Biglarnia AR, Nilsson B, Nilsson T, von Zur-Mühlen B, Wagner M, Berne C, Wanders A, Magnusson A, Tufveson G. Biglarnia AR, et al. Among authors: wanders a. Transpl Int. 2011 Aug;24(8):e61-6. doi: 10.1111/j.1432-2277.2011.01290.x. Epub 2011 Jun 22. Transpl Int. 2011. PMID: 21696455 Free article.

2

Enhancement of the effect of low-dose cyclosporin A by sulphasalazine in prevention of cardiac allograft rejection in the rat.

Wanders A, Tufveson G, Gerdin B. Wanders A, et al. Transpl Int. 1992 Jul;5(3):155-8. doi: 10.1007/BF00336601. Transpl Int. 1992. PMID: 1355339

3

Effects of prostaglandin E2 (PGE2) and drugs affecting PGE2 degradation on acute rejection of rat cardiac allografts.

Wanders A, Tufveson G, Gerdin B. Wanders A, et al. Scand J Thorac Cardiovasc Surg. 1992;26(1):33-7. doi: 10.3109/14017439209099050. Scand J Thorac Cardiovasc Surg. 1992. PMID: 1529295

4

Mode of action of immunosuppressive drugs evaluated with the aid of the immunostimulator LS-2616: studies on rejecting rat cardiac allografts.

Wanders A, Gannedahl G, Gerdin B, Tufveson G. Wanders A, et al. Transplant Proc. 1992 Feb;24(1):274-5. Transplant Proc. 1992. PMID: 1539280 No abstract available.

5

Gamma-interferon-like substance is expressed in myocytes of cardiac allografted rats treated with cyclosporine A.

Wanders A, Wells AF, Tufveson G, Klareskog L. Wanders A, et al. Transplant Proc. 1992 Feb;24(1):346. Transplant Proc. 1992. PMID: 1539309 No abstract available.

6

Expression of an interferon-gamma-like substance in normal and transplanted rat heart tissue.

Wanders A, Wells AF, Larsson E, Tufveson G, Olsson T, Ljungdahl A, Klareskog L. Wanders A, et al. J Heart Lung Transplant. 1992 Jan-Feb;11(1 Pt 1):142-6. J Heart Lung Transplant. 1992. PMID: 1540602

7

Evidence that LS-2616 (linomide) causes acute rejection of rat allografts protected by cyclosporine but not of long-term surviving allografts.

Wanders A, Vogt P, Karlsson-Parra A, Wonigkeit K, Gerdin B, Tufveson G. Wanders A, et al. Transplantation. 1991 Aug;52(2):234-8. doi: 10.1097/00007890-199108000-00010. Transplantation. 1991. PMID: 1871795

8

Abolition of the effect of cyclosporine on rat cardiac allograft rejection by the new immunomodulator LS-2616 (Linomide).

Wanders A, Larsson E, Gerdin B, Tufveson G. Wanders A, et al. Transplantation. 1989 Feb;47(2):216-7. doi: 10.1097/00007890-198902000-00003. Transplantation. 1989. PMID: 2645700

9

Rat cardiac allografts protected with cyclosporin A are rejected in the presence of LS-2616 (Linomide).

Gerdin B, Wanders A, Tufveson G. Gerdin B, et al. Among authors: wanders a. Transplant Proc. 1989 Feb;21(1 Pt 1):853-5. Transplant Proc. 1989. PMID: 2650284 No abstract available.

10

The enhancing effect of cyclosporine A and sulfasalazine on the prevention of rejection in rat cardiac allografts.

Wanders A, Tufveson G, Gerdin B. Wanders A, et al. Transpl Int. 1988 Jul;1(2):113-5. doi: 10.1007/BF00353831. Transpl Int. 1988. PMID: 2908220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters